
Services and contacts |
|
Our core services to pharmaceuticals companies include:
Our deep understanding of regulation and legislation means we can help
companies with complex reporting requirements, such as Sarbanes-Oxley and IFRS.
We are leaders in the development of non-financial reporting, such as the
Operating and Financial Review (OFR), to help our clients respond to the drive
for better corporate governance.
Simon Friend, +44 (0) 20 7213 4875
Our sustainable business solutions team helps clients improve their business
performance and long-term shareholder value with a focus on ethical
standards.
Jennifer Woodward, +44 (0) 20 7804
1871
Helps corporate and private equity clients maximise the return on their
deals and reduce risk. Our services include strategic reviews, deal due
diligence, no-access due diligence, merger benefits analysis, post-acquisition
integration, carve-outs, vendor assistance, vendor due diligence and bid
support.
Lucy Stapleton, +44 (0) 20 7804
2629
Provides a full range of industry-focused financial advisory services to
corporates, management teams, private equity houses and public sector
institutions. We offer advice throughout the deal spectrum; from strategy,
valuation and execution through to exit planning; and on a range of transaction
types including M&A, private equity, IPOs, project finance and
PPP.
Neal Ransome, +44 (0) 20 7213 1015
Helps companies react with agility to opportunities and threats by
delivering performance improvements that allow them to gain and protect
competitive advantage. We work with our clients to provide solutions across the
value chain including maximising potential in R&D, enhancing existing
operations, manufacturing cost reduction and maximising revenues through sales
and marketing.
Sandy Johnston, +44 (0) 20 7213
1952
Helps organisations tackle the major financial and reputational risks
associated with economic crime. Our forensic experts identify financial
irregularities, recover stolen assets and introduce controls to mitigate the
future risk of fraud. The team also has a long-established litigation support
practice, helping businesses resolve complex financial disputes arising from
corporate transactions, insurance claims, intellectual property and licensing
contracts, and construction projects.
Angus Brown, +44 20 (0) 7212 4687
Although companies commit significant amounts of time and resources
researching, negotiating and implementing collaborations with its partners,
many companies fail to effectively monitor their partner’s compliance.
Clive Birch, +44 (0) 1223 55 2303
Find out more: Licensing management services - life sciences (279K PDF)
Develops and applies best practices combining all aspects of tax planning
and problem solving from ideas to implementation, blending the skills of
financial and tax specialists with economists, lawyers and other in-house
experts as necessary.
Andrew Packman, +44 (0) 1895
522104
The life sciences sector spends vast amounts on R&D. A large number of
claims are missed or underestimated because the R&D tax credit legislation
is sometimes difficult to apply to technology R&D
Clive Birch, +44 (0) 1223 55 2303
Find out more: R&D tax credits - life sciences (85K PDF)
Advises companies on all aspects of people management, helping them create
value for their businesses through people. Key issues are executive reward
schemes, negotiating Inland Revenue agreements, dispensations and annual PAYE
settlement agreements; and dealing with pension scheme deficits.
George Yeandle, +44 (0) 20 7212
4638
Bookmark with: